Clinical trial
Study of Oxaliplatin and Taxotere in Prostate Cancer
NCT00260611 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00260611 |
|---|---|
| Title | Study of Oxaliplatin and Taxotere in Prostate Cancer |
| Official title | Study of Oxaliplatin and Taxotere in Androgen Independent Prostate Cancer |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Oxaliplatin, Taxotere |
| Enrollment | 34 |
| Start date | Nov 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Dec 1, 2005 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: